These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20340137)

  • 1. Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease.
    Voutsinas GE; Stavrou EF; Karousos G; Dasoula A; Papachatzopoulou A; Syrrou M; Verkerk AJ; van der Spek P; Patrinos GP; Stöger R; Athanassiadou A
    Hum Mutat; 2010 Jun; 31(6):685-91. PubMed ID: 20340137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
    Chiba-Falek O; Lopez GJ; Nussbaum RL
    Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of eukaryotic expression vector containing hSNCA gene and its pathogenic mutants and its expression in PC12 cells].
    Qian JJ; Cheng YB; Liu CF; Yang YP; Liu KY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jan; 24(1):23-6. PubMed ID: 18177612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
    Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N
    Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
    Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain.
    Fuchs J; Tichopad A; Golub Y; Munz M; Schweitzer KJ; Wolf B; Berg D; Mueller JC; Gasser T
    FASEB J; 2008 May; 22(5):1327-34. PubMed ID: 18162487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNP rs7684318 of the alpha-synuclein gene is associated with Parkinson's disease in the Han Chinese population.
    Yu L; Xu P; He X; Hu F; Lin Z; Zhu M; Liu Z; He L; Xu Y
    Brain Res; 2010 Jul; 1346():262-5. PubMed ID: 20513365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.
    Mizuta I; Satake W; Nakabayashi Y; Ito C; Suzuki S; Momose Y; Nagai Y; Oka A; Inoko H; Fukae J; Saito Y; Sawabe M; Murayama S; Yamamoto M; Hattori N; Murata M; Toda T
    Hum Mol Genet; 2006 Apr; 15(7):1151-8. PubMed ID: 16500997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA--a key player in the pathogenesis of Parkinson's disease.
    Häbig K; Walter M; Stappert H; Riess O; Bonin M
    Brain Res; 2009 Feb; 1256():19-33. PubMed ID: 19135032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
    Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
    Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.
    Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D
    FASEB J; 2008 Oct; 22(10):3509-14. PubMed ID: 18606870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
    Cabin DE; Gispert-Sanchez S; Murphy D; Auburger G; Myers RR; Nussbaum RL
    Neurobiol Aging; 2005 Jan; 26(1):25-35. PubMed ID: 15585343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
    Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
    Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.
    Ikeuchi T; Kakita A; Shiga A; Kasuga K; Kaneko H; Tan CF; Idezuka J; Wakabayashi K; Onodera O; Iwatsubo T; Nishizawa M; Takahashi H; Ishikawa A
    Arch Neurol; 2008 Apr; 65(4):514-9. PubMed ID: 18413475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threonine 53 in alpha-synuclein is conserved in long-living non-primate animals.
    Larsen K; Hedegaard C; Bertelsen MF; Bendixen C
    Biochem Biophys Res Commun; 2009 Sep; 387(3):602-5. PubMed ID: 19619507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms.
    Ibáñez P; Lesage S; Janin S; Lohmann E; Durif F; Destée A; Bonnet AM; Brefel-Courbon C; Heath S; Zelenika D; Agid Y; Dürr A; Brice A;
    Arch Neurol; 2009 Jan; 66(1):102-8. PubMed ID: 19139307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene dosage and pathogenesis of Parkinson's disease.
    Eriksen JL; Przedborski S; Petrucelli L
    Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
    Pals P; Lincoln S; Manning J; Heckman M; Skipper L; Hulihan M; Van den Broeck M; De Pooter T; Cras P; Crook J; Van Broeckhoven C; Farrer MJ
    Ann Neurol; 2004 Oct; 56(4):591-5. PubMed ID: 15455394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes.
    Mutez E; Leprêtre F; Le Rhun E; Larvor L; Duflot A; Mouroux V; Kerckaert JP; Figeac M; Dujardin K; Destée A; Chartier-Harlin MC
    Hum Mutat; 2011 Apr; 32(4):E2079-90. PubMed ID: 21412942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease.
    Deng H; Xie W; Guo Y; Le W; Jankovic J
    Mov Disord; 2006 May; 21(5):728-9. PubMed ID: 16552756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.